Gala Pharmaceutical Inc. Accretion Expense
Gala Pharmaceutical Inc. reported Accretion Expense of $44.84 thousand for the 6-month period ending 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2019-07-23
- Gala Pharmaceutical Inc. accretion expense for the quarter ending 2019-05-31 was $34.97K.
- Gala Pharmaceutical Inc. accretion expense for the quarter ending 2019-02-28 was $9.88K.
- Gala Pharmaceutical Inc. accretion expense for the quarter ending 2018-05-31 was $0.00.
- Gala Pharmaceutical Inc. accretion expense for the quarter ending 2018-02-28 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month |
|---|---|---|
| 2019-05-31 | $34.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-23 | $44.84K 10-Q · filed 2019-07-23 |
| 2019-02-28 | $9.88K 10-Q · filed 2019-04-30 | |
| 2018-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-23 | $0.00 10-Q · filed 2019-07-23 |
| 2018-02-28 | $0.00 10-Q · filed 2019-04-30 |